In the future, clinical guidelines might include AGT genotyping, with other molecular biomarkers [19], as part of the process for choosing antihypertensive treatment, which could help move toward more personalized treatment for hypertension [20]. The gene discussed is AGT; the disease is hypertensive disorder.